Your session is about to expire
← Back to Search
Ketoconazole for Insulin Resistance
Study Summary
This trial is studying the effects of sleep restriction on the production of two hormones, cortisol and testosterone. The goal is to see if changing these hormones leads to insulin resistance, which is a cause of type 2 diabetes mellitus. The trial may also study the effect of sleep restriction on food intake and cravings, mood, inflammation, metabolism (including bone), and other hormones.
Timeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Trial Design
Find a Location
Who is running the clinical trial?
Media Library
- You have a history of brain injury or learning disability.You are currently smoking cigarettes.You have trouble sleeping or have a disorder that affects your sleep patterns.You have had a bad reaction to staying awake for long periods of time or to any of the medications that will be given.Your body mass index (BMI) is between 20 and 28 kg/m2.You have recently used or are currently using drugs or alcohol excessively.You have a history of mental health problems.You have certain medical conditions or illnesses.You have difficulty seeing or hearing, unless it can be fixed with corrective measures to bring it back to normal.
- Group 1: Placebo and Drug Group 2
- Group 2: Drug and Placebo Group 1
- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
Are there vacancies open to prospective participants of this research?
"At this time, the trial is not recruiting patients. It was posted on October 1st 2014 and last updated March 11th 2022. Fortunately, there are 163 other medical studies looking for individuals with insulin resistance; 95 of those trials are actively seeking participants."
Have additional experiments been conducted involving this therapeutic approach?
"Currently, a total of 95 studies are actively assessing this intervention; out of these trials, 26 have entered Phase 3. In Hefei, Anhui alone there is an abundance of sites researching the treatment's efficacy and safety with 3191 locations overall taking part in related clinical trials."
How many people are enrolled in the trial at maximum capacity?
"Unfortunately, this particular trial is not in its recruitment phase. It was posted on October 1st 2014 and last edited on March 11th 2022. However, there are 163 other trials currently recruiting patients with insulin resistance and 95 studies for the same treatment actively enlisting participants."
To what specific conditions is this intervention typically administered?
"This particular treatment can be implemented to alleviate the symptoms of varicella-zoster virus acute retinal necrosis, vaginal candidiasis and iritis."
Are geriatric individuals being accepted in this research program?
"Those seeking to partake in this trial must be aged between 22 and 45 years old."
Is it likely that I would be eligible to participate in this clinical trial?
"To partake in this medical trial, potential patients must possess insulin resistance and be between 22 and 45 years old. Approximately 40 individuals are sought for the study."
Other Trials to Consider
Popular Categories
Share this study with friends
Copy Link
Messenger